Loading...
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
Daniela Pugliese, Carla Felice, Rosario Landi, Alfredo Papa, Luisa Guidi, Alessandro Armuzzi Inflammatory Bowel Disease Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy Abstract: Significant advances in the management of patients with ulcerative colitis (UC) have been made since...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2016-02-01
|
| Series: | Drug, Healthcare and Patient Safety |
| Subjects: | |
| Online Access: | https://www.dovepress.com/benefitndashrisk-assessment-of-golimumab-in-the-treatment-of-refractor-peer-reviewed-article-DHPS |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|